Sarah Cavanaugh Celldex Therapeutics, Inc. (CLDX) insider trading activity
Sarah Cavanaugh is SVP OF CORP AFFAIRS & ADMIN. of Celldex Therapeutics, Inc.. Currently has a direct ownership of 1,860 shares of CLDX, which is worth approximately $47,764. The most recent transaction as insider was on May 30, 2024, when has been sold 20,853 shares (Common Stock) at a price of $33.73 per share, resulting in proceeds of $703,371. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.86K
0%
3M change
44.86%
12M change
Total Value Held
$47,764
Sarah Cavanaugh Transaction History
SC
Sarah Cavanaugh
SVP OF CORP AFFAIRS & ADMIN.
Hampton, NJ